Skip to main content
Top
Published in:

Open Access 21-06-2024 | Craniosynostosis | Research

Early posterior vault distraction osteogenesis changes the syndromic craniosynostosis treatment paradigm: long-term outcomes of a 23-year cohort study

Authors: Meagan Wu, Sarah L. Barnett, Benjamin B. Massenburg, Jinggang J. Ng, Dominic J. Romeo, Jesse A. Taylor, Scott P. Bartlett, Jordan W. Swanson

Published in: Child's Nervous System | Issue 9/2024

Login to get access

Abstract

Background

Early surgical management of syndromic craniosynostosis varies widely between centers, with patients typically undergoing multiple intracranial procedures through childhood. This study evaluates the long-term impact of early posterior vault distraction osteogenesis (PVDO) versus conventional treatment paradigms on the number and timing of subsequent craniofacial procedures.

Methods

We retrospectively analyzed the longitudinal operative patterns of patients with syndromic craniosynostosis treated from 2000 to 2023 with greater than five years of follow-up. Outcomes of patients who underwent early PVDO and conventional vault reconstruction were compared.

Results

Fifty-five patients met the inclusion criteria (30 PVDO and 25 conventional). Age at initial vault surgery was similar between the PVDO and conventional cohorts (7.6 vs. 8.8 months), as were baseline craniometrics (p > 0.05). Multiple fronto-orbital advancement (FOA) procedures were performed in only 1/30 (3%) PVDO-treated patient versus 12/25 (48%) conventionally-treated patients (p < 0.001). Twelve (40%) PVDO-treated patients did not undergo FOA at all. Among patients with Apert and Crouzon syndromes, fewer PVDO-treated patients required FOA prior to midface surgery (33% vs. 92%, p = 0.004) or repeat FOA (6% vs. 50%, p = 0.005) compared to conventionally-treated patients. Among patients with Muenke and Saethre–Chotzen syndromes, a similar proportion of patients required FOA in the PVDO and conventional cohorts (91% vs. 100%, p = 0.353), though no PVDO-treated patients required repeat FOA (0% vs. 44%, p = 0.018).

Conclusions

Early PVDO is associated with a reduction in the high burden of both FOA and, critically, revisionary frontal procedures which are commonly seen in conventionally-treated patients with syndromic craniosynostosis.
Appendix
Available only for authorised users
Literature
36.
go back to reference McCarthy JG, Glasberg SB, Cutting CB et al (1995) Twenty-year experience with early surgery for craniosynostosis: II. The craniofacial synostosis syndromes and pansynostosis–results and unsolved problems. Plast Reconstr Surg 96(2):284–295 discussion 296-8CrossRefPubMed McCarthy JG, Glasberg SB, Cutting CB et al (1995) Twenty-year experience with early surgery for craniosynostosis: II. The craniofacial synostosis syndromes and pansynostosis–results and unsolved problems. Plast Reconstr Surg 96(2):284–295 discussion 296-8CrossRefPubMed
38.
go back to reference Muenke M, Gripp KW, McDonald-McGinn DM et al (1997) A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 60(3):555–564PubMedPubMedCentral Muenke M, Gripp KW, McDonald-McGinn DM et al (1997) A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 60(3):555–564PubMedPubMedCentral
Metadata
Title
Early posterior vault distraction osteogenesis changes the syndromic craniosynostosis treatment paradigm: long-term outcomes of a 23-year cohort study
Authors
Meagan Wu
Sarah L. Barnett
Benjamin B. Massenburg
Jinggang J. Ng
Dominic J. Romeo
Jesse A. Taylor
Scott P. Bartlett
Jordan W. Swanson
Publication date
21-06-2024
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 9/2024
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-024-06465-x

How can you integrate PET into your practice? (Link opens in a new window)

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Register your interest

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video